GlassScriptPhysician profile
Javier J Avila
NPI 1477641504
$916.97
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $590 · 2022: $206 · 2023: $40.14 · 2024: $80.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $114.64 | 2021-2022 | |
| Biogen, INC. | $107.48 | 2021-2022 | |
| Nevro Corp. | $104.20 | 2022 | |
| Allergan, INC. | $73.29 | 2021 | |
| Nalu Medical, INC. | $71.89 | 2021 | |
| Linvatec Corporation | $61.92 | 2024 | Biobrace 23mm, Allograft Tissue |
| Scilex Pharmaceuticals INC. | $59.23 | 2021 | |
| Forte Bio-Pharma LLC | $43.88 | 2021 | |
| Emd Serono, INC. | $41.83 | 2022-2023 | Mavenclad |
| Boston Scientific Corporation | $35.02 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $33.55 | 2021 | |
| Almatica Pharma LLC | $29.60 | 2021 | |
| Upsher-Smith Laboratories LLC | $18.69 | 2021 | |
| Lilly USA, LLC | $17.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.75 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $16.31 | 2021 | |
| Mannkind Corporation | $16.20 | 2021 | |
| Redhill Biopharma INC. | $15.75 | 2021 | |
| Amgen INC. | $13.23 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.42 | 2021 | |
| Si-Bone, INC. | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Avila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.